Randomized comparison of intranasal and transdermal estradiol

Obstetrics and Gynecology

Volumn 96, Issue 6, 2000, Pages 906-912

  Lopes, Patrice ^a   Merkus, Hans M W M ^b   Nauman, Janusz ^c   Bruschi, Fiorenza ^d   Foidart, Jean Michel ^e   Calaf, Joaquin ^f  

^a Perinatology Unit   (France)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d UNIVERSITY OF MILAN   (Italy)

^e Centre Hospitalier Regional de La Citadelle   (Belgium)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ADULT; AGED; ARTICLE; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ESTROGEN THERAPY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; PATIENT SATISFACTION; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SWEATING; TRANSDERMAL PATCH; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRANASAL; ADULT; AGED; CLIMACTERIC; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; TREATMENT OUTCOME;

EID: 0033741778     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)01041-3     Document Type: Article

References (25)

1. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices
2. Hormonal treatment of postmenopausal women
3. The menopause
4. Estrogens, bone loss, and preservation
5. Hormone therapy to prevent disease and prolong life in postmenopausal women
6. Estrogen replacement therapy and fractures in older women
7. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
8. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
9. Pharmacokinetic and pharmacologic variation between different estrogen products
10. Biological effects of estradiol-17 beta in postmenopausal women: Oral versus percutaneous administration
11. A randomized comparison of nonoral estradiol delivery in postmenopausal women
12. Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate
13. Randomised cross-over comparison of skin irritation with two transdermal oestradiol patches
14. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies
15. Pharmacokinetics of estradiol administered by nasal spray (S21400) to postmenopausal women with comparison to transdermal and oral formulations
16. Dose-response study of the efficacy and acceptability of intranasal 17 β-oestradiol for menopausal symptoms
17. Clinical equivalence of intranasal and oral 17 β-estradiol for postmenopausal symptoms
18. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double blind placebo-controlled study
19. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
20. Intranasal estradiol administration to oophorectomized women
21. Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study
22. A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study Group
23. Effects of transdermal oestrogen therapy in postmenopausal women: A comparative study of an oestradiol gel and an oestradiol delivering patch
24. The need to improve compliance to HRT
25. Patient noncompliance with hormone replacement therapy: A nationwide estimate using a large prescription claims database